The pragmatic role of nasal cytology: a point-of-care testing to implement precision medicine in clinical practice
- PMID: 30176204
- DOI: 10.29262/ram.v65i3.373
The pragmatic role of nasal cytology: a point-of-care testing to implement precision medicine in clinical practice
Abstract
Background: Precision medicine is an up-to-date strategy aimed at individualizing precise pathophysiological mechanisms. Thus, precision medicine is the basis for personalized medicine, inasmuch as it seeks to define the most appropriate treatment for each patient. Nasal cytology requires only an optical microscope, stains, glasses, and nasal cytology curettes. The procedure may last very few minutes using quick staining and, therefore, it can be considered a reliable point-of-care test in the office setting.
Methods: Cross-sectional study that included 5030 outpatients with nasal disorders: 2612 males and 2418 females, with a mean age of 36.8 ± 17.1 years, who were attended to within a 5-year period. The patients were subdivided according to skin prick-test and nasal cytology results into subjects with allergic rhinitis or non-allergic rhinitis. Cellular forms were further subdivided based on their cytotype: NARNE (> 50% of neutrophils with absence of spores and bacteria); NARES (> 20% of eosinophils); NARMA (> 10% of mast cells); and NARESMA (> 20% of eosinophils and > 10% of mast cells).
Results: 453 subjects (9%) had negative nasal cytology, 1056 (21%) had allergic rhinitis, 538 (10.7%) had NARES, 493 (9.8%) had nasal polyposis, 251 (5%) had rhinosinusitis, 221 (4.4%) had NARESMA 201 (4%) had infectious rhinitis, 131 (2.6%) had NARMA, 89 (1.8%) had NARNE, with the remaining subjects having a miscellaneous inflammatory/infectious profile.
Conclusions: Nasal cytology provides quick information about phenotype and endotype and can be repeated during follow-up to assess post-treatment changes.
Antecedentes: La medicina de precisión es una estrategia actualizada que apunta a individualizar los mecanismos fisiopatológicos precisos. Entonces, la medicina de precisión es la base de la medicina personalizada, como definir el tratamiento apropiado en cada paciente. La citología nasal solo necesita un microscopio óptico, tinturas, gafas y curetas. El procedimiento puede durar muy pocos minutos usando tinción rápida, por lo tanto, se puede considerar una prueba confiable en el punto de atención en el consultorio. Métodos: Estudio transversal que incluyó 5030 pacientes ambulatorios con trastornos nasales: 2612 hombres y 2418 mujeres, edad promedio de 36.8 ± 17.1 años, quienes fueron atendidos en un periodo de cinco años. Los pacientes se subdividieron conforme a la prueba cutánea y la citología nasal en sujetos con rinitis alérgica y con rinitis no alérgica. Las formas celulares se subdividieron en función del citotipo: rinitis no alérgica con predominio de infiltración eosinofílica (NARNE, neutrófilos > 50 % con esporas y bacterias ausentes); rinitis no alérgica con eosinófilos (NARES, eosinófilos > 20%); rinitis no alérgica con predominio de infiltrado de mastocitos (NARMA, mastocitos > 10 %) y rinitis no alérgica con eosinófilos y mastocitos (NARESMA, eosinófilos > 20 % y mastocitos > 10 %). Resultados: 453 (9 %) sujetos tuvieron citología negativa a nasal, 1056 (21 %) rinitis alérgica, 538 (10.7%) NARES, 493 (9.8%) poliposis nasal, 251 (5%) rinosinusitis, 221 (4.4%) NARESMA, 201 (4%) rinitis infecciosa; 131 (2.6%) NARMA y 89 (1.8%) NARNE; los sujetos restantes tenían un perfil inflamatorio-infeccioso misceláneo. Conclusiones: La citología nasal proporciona información rápida sobre el fenotipo y endotipo y puede repetirse en el seguimiento para evaluar los cambios posteriores al tratamiento.
Keywords: Allergy; Nasal cytology; Precision medicine; Rhinitis.
Similar articles
-
Middle meatus nasal cytology compared to inferior turbinate cytology in non allergic rhinitis.Eur Arch Otorhinolaryngol. 2023 Feb;280(2):913-918. doi: 10.1007/s00405-022-07629-8. Epub 2022 Aug 31. Eur Arch Otorhinolaryngol. 2023. PMID: 36044075
-
Clinical efficacy of nasal steroids on nonallergic rhinitis and the associated inflammatory cell phenotypes.Am J Rhinol Allergy. 2015 Sep-Oct;29(5):343-9. doi: 10.2500/ajra.2015.29.4234. Am J Rhinol Allergy. 2015. PMID: 26358345 Clinical Trial.
-
Non-allergic rhinitis with eosinophils and mast cells constitutes a new severe nasal disorder.Int J Immunopathol Pharmacol. 2008 Apr-Jun;21(2):325-31. doi: 10.1177/039463200802100209. Int J Immunopathol Pharmacol. 2008. PMID: 18547476
-
Nasal cytology in children: recent advances.Ital J Pediatr. 2012 Sep 25;38:51. doi: 10.1186/1824-7288-38-51. Ital J Pediatr. 2012. PMID: 23009215 Free PMC article. Review.
-
Nasal cytology: Methodology with application to clinical practice and research.Clin Exp Allergy. 2018 Sep;48(9):1092-1106. doi: 10.1111/cea.13207. Epub 2018 Jul 9. Clin Exp Allergy. 2018. PMID: 29904978 Review.
Cited by
-
Novel therapeutic targets for allergic airway disease in children.Drugs Context. 2019 Jul 9;8:212590. doi: 10.7573/dic.212590. eCollection 2019. Drugs Context. 2019. PMID: 31391855 Free PMC article. Review.
-
Nasal cytology and histology in CRSwNP: Two sides of the same coin.Front Med (Lausanne). 2023 Mar 9;10:1143351. doi: 10.3389/fmed.2023.1143351. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36968832 Free PMC article.
-
Mometasone Furoate in Non-Allergic Rhinitis: A Real-Life Italian Study.J Pers Med. 2022 Jul 20;12(7):1179. doi: 10.3390/jpm12071179. J Pers Med. 2022. PMID: 35887676 Free PMC article.
-
Nasal cytology identifies healthy and damaged nasal epithelial cells - Reply.Acta Biomed. 2020 Mar 19;91(1):148-149. doi: 10.23750/abm.v91i1.9264. Acta Biomed. 2020. PMID: 32191673 Free PMC article. No abstract available.
-
Scraping nasal cytology in the diagnostics of rhinitis and the comorbidities.Sci Rep. 2022 Aug 25;12(1):14492. doi: 10.1038/s41598-022-18734-3. Sci Rep. 2022. PMID: 36008516 Free PMC article.
MeSH terms
LinkOut - more resources
Other Literature Sources